论文部分内容阅读
研究背景:β-受体阻滞剂能够减少高血压病和2型糖尿病的心血管风险。然而,β-受体阻滞剂在一定程度上会导致代谢综合征加重。在接受肾素-血管紧张素系统(RAS)阻滞剂治疗的糖尿病合并高血压病的患者,不同的β-受体阻滞剂对血糖和代谢的影响有所不同。本研究旨在探讨不同类型的β
Background: β-blockers reduce the cardiovascular risk of hypertension and type 2 diabetes. However, β-blockers to a certain extent lead to worsening metabolic syndrome. The effects of different beta-blockers on blood glucose and metabolism are different in patients with diabetes mellitus and hypertension who are treated with renin-angiotensin system (RAS) blockers. This study aimed to explore different types of β